[conteúdo em construção]

Anticoncepcionais e a falha em suprimir a ovulação

  1. Killick S, Eyong E, Elstein M. Ovarian follicular development in oral contraceptive cycles. Fertil Steril. 1987;48:409–13 pubmed
  2. (2) Hamilton CJ, Hoogland HJ. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. Am J Obstet Gynecol. 1989;161:1159–62 pubmed
  3. (3) Young RL, Snabes MC, Frank ML, Reilly M. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. Am J Obstet Gynecol. 1992;167:678–82 pubmed
  4. (4) Broome M, Clayton J, Fotherby K. Enlarged follicles in women using oral contraceptives. Contraception. 1995;52:13–6 pubmed
  5. (5) Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 1995;9:299–305 pubmed
  6. (6) Coney P, DelConte A. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol. Am J Obstet Gynecol. 1999;181:53–8 pubmed
  7. (7) Pierson R, Archer D, Moreau M, Shangold G, Fisher A, Creasy G, et al. SGiA: Ortho EVRA™ vs oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril. 2003;80(1):34–42 pubmed
  8. (8) London A, Jensen JT. Rationale for eliminating the hormone-free interval in modern oral contraceptives. Int J Gynaecol Obstet. 2016;134(1):8-12 pubmed
  9. (9) Van Heusden AM, Fauser BC. Residual ovarian activity during oral steroid contraception. Hum Reprod Update. 2002;8:345–58 pubmed

Autonomia do embrião

  1. Shahbazi MN, Jedrusik A, Vuoristo S, Recher G, Hupalowska A, Bolton V, Fogarty NNM, Campbell A, Devito L, Ilic D, Khalaf Y, Niakan KK, Fishel S, Zernicka-Goetz M. 2016. Self-organization of the human embryo in the absence of maternal tissues. Nat Cell Biol. Jun;18(6):700-708 pubmed

Mecanismos de ação do DIU

Prejuízo na implantação:

1. Stanford JB, Mikolajczyk RT. 2002. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol. Dec;187(6):1699-708. pubmed

2. ESHRE Capri Workshop Group. 2008. Intrauterine devices and intrauterine systems. Hum Reprod Update. May-Jun;14(3):197-208. pubmed

2. Savaris R1, Zettler CG, Ferrari AN. 2000. Expression of alpha4beta1 and alphavbeta3 integrins in the endometrium of women using the T200 copper intrauterine device. Fertil Steril. Dec;74(6):1102-7. pubmed